Amneal Pharmaceuticals (AMRX) Profit After Tax Growth (1y) (2018 - 2026)
Amneal Pharmaceuticals (AMRX) Profit After Tax Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | 95.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.49% |
| Mar 31, 2026 | 410.50% |
| Dec 31, 2025 | 177.76% |
| Sep 30, 2025 | -79.85% |
| Jun 30, 2025 | 273.99% |
| Mar 31, 2025 | 113.31% |
| Dec 31, 2024 | 35.37% |
| Sep 30, 2024 | 21.43% |
| Jun 30, 2024 | -79.81% |
| Mar 31, 2024 | -1,219.93% |
| Dec 31, 2023 | -2,717.38% |
| Sep 30, 2023 | 227.18% |
| Jun 30, 2023 | 112.36% |
| Mar 31, 2023 | 21.25% |
| Dec 31, 2022 | 118.42% |
| Sep 30, 2022 | -24.97% |
| Jun 30, 2022 | -846.15% |
| Mar 31, 2022 | -160.62% |
| Dec 31, 2021 | -193.87% |
| Sep 30, 2021 | 71.85% |